| Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
| contig05901 |
hect domain containing 3 |
463 |
20 |
7.73E-79 |
78.45% |
4 |
C:intracellular; P:cell adhesion; P:ubiquitin cycle; F:ubiquitin-protein ligase activity |
EC:6.3.2.19 |
|
| contig05902 |
general transcription factor polypeptide 52kda |
479 |
20 |
7.85E-68 |
88.70% |
54 |
F:valine-tRNA ligase activity; C:MHC class I protein complex; P:protein amino acid glycosylation; P:protein amino acid phosphorylation; P:protein folding; F:zinc ion binding; C:actin filament; F:tumor necrosis factor receptor binding; F:steroid hormone receptor activity; P:cell adhesion; P:transcription from RNA polymerase II promoter; C:MHC class II protein complex; P:metal ion transport; C:phagocytic cup; C:PML body; ; P:regulation of small GTPase mediated signal transduction; F:ganglioside galactosyltransferase activity; P:immune response; P:cell morphogenesis; F:metal ion transmembrane transporter activity; P:phosphate transport; F:extracellular matrix structural constituent; C:extracellular space; F:protein N-terminus binding; P:androgen receptor signaling pathway; F:calcium ion binding; C:integral to membrane; P:negative regulation of transcription, DNA-dependent; C:Golgi apparatus; P:transmembrane receptor protein tyrosine kinase signaling pathway; F:RNA polymerase II transcription factor activity; C:holo TFIIH complex; C:ruffle; C:prefoldin complex; F:sequence-specific DNA binding; P:valyl-tRNA aminoacylation; P:apoptosis; F:steroid binding; C:heterochromatin; F:unfolded protein binding; F:transcription factor activity; P:cytokinesis after mitosis; F:transmembrane receptor protein tyrosine kinase activity; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; C:collagen; F:protein homodimerization activity; F:transcription factor binding; F:ATP binding; P:actin filament bundle assembly; F:androgen receptor binding; F:transcription repressor activity; P:DNA repair; F:guanyl-nucleotide exchange factor activity |
EC:6.1.1.9; EC:2.4.1.62; EC:2.7.10.1 |
|
| contig05903 |
trafficking protein particle complex 2 |
241 |
20 |
9.75E-26 |
97.65% |
6 |
C:Golgi apparatus; P:skeletal system development; F:transcription factor binding; P:ER to Golgi vesicle-mediated transport; C:endoplasmic reticulum; P:regulation of transcription, DNA-dependent |
|
|
| contig05904 |
transducin-like enhancer of split 3 (e drosophila) isoform 1 |
320 |
20 |
3.09E-19 |
100.00% |
5 |
P:spermatogenesis; P:cell differentiation; P:multicellular organismal development; C:nucleus; P:regulation of transcription, DNA-dependent |
|
|
| contig05905 |
uridine-cytidine kinase 1-like 1 |
479 |
20 |
1.03E-35 |
92.65% |
6 |
F:uridine kinase activity; P:metabolic process; F:ATP binding; C:cytoplasm; F:phosphotransferase activity, alcohol group as acceptor; C:nucleus |
EC:2.7.1.48; EC:2.7.1.0 |
|
| contig05906 |
---NA--- |
343 |
0 |
|
|
0 |
|
|
|
| contig05907 |
mcm3 minichromosome maintenance deficient 3 |
250 |
20 |
5.85E-23 |
93.60% |
9 |
P:regulation of DNA replication initiation; P:cell cycle; P:regulation of transcription, DNA-dependent; C:MCM complex; F:DNA binding; F:ATP binding; F:DNA-dependent ATPase activity; P:retina development in camera-type eye; F:chromatin binding |
|
|
| contig05908 |
---NA--- |
361 |
0 |
|
|
0 |
|
|
|
| contig05909 |
---NA--- |
428 |
0 |
|
|
0 |
|
|
|
| contig05910 |
chromatin modifying protein 4c |
340 |
2 |
3.68E-09 |
83.00% |
5 |
F:F; C:cytoplasm; P:transport; P:protein transport; C:C |
|
|
| contig05911 |
f-box and wd-40 domain protein 11a |
336 |
1 |
4.68E-04 |
88.00% |
0 |
|
|
|
| contig05912 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
| contig05913 |
---NA--- |
217 |
0 |
|
|
0 |
|
|
|
| contig05914 |
---NA--- |
274 |
0 |
|
|
0 |
|
|
|
| contig05915 |
---NA--- |
516 |
0 |
|
|
0 |
|
|
|
| contig05916 |
---NA--- |
263 |
0 |
|
|
0 |
|
|
|
| contig05917 |
---NA--- |
248 |
0 |
|
|
0 |
|
|
|
| contig05918 |
---NA--- |
278 |
0 |
|
|
0 |
|
|
|
| contig05919 |
proline-rich protein bca3 |
452 |
10 |
5.94E-23 |
53.70% |
0 |
|
|
|
| contig05920 |
---NA--- |
273 |
0 |
|
|
0 |
|
|
|
| contig05921 |
---NA--- |
310 |
0 |
|
|
0 |
|
|
|
| contig05922 |
---NA--- |
261 |
0 |
|
|
0 |
|
|
|
| contig05923 |
wd repeat and hmg-box dna binding protein 1 |
631 |
20 |
5.44E-76 |
74.60% |
3 |
C:cytoplasm; C:nucleoplasm; F:DNA binding |
|
|
| contig05924 |
---NA--- |
263 |
0 |
|
|
0 |
|
|
|
| contig05925 |
---NA--- |
153 |
0 |
|
|
0 |
|
|
|
| contig05926 |
basigin |
913 |
20 |
1.31E-108 |
68.20% |
1 |
C:membrane |
|
|
| contig05927 |
PREDICTED: wu:fb21f05 [Danio rerio] |
367 |
2 |
3.55E-20 |
69.00% |
0 |
|
|
|
| contig05928 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
| contig05929 |
las1-like ( cerevisiae) |
354 |
20 |
2.24E-46 |
75.45% |
1 |
F:protein binding |
|
|
| contig05930 |
nitrilase 1 |
244 |
20 |
6.08E-28 |
75.45% |
1 |
F:nitrilase activity |
EC:3.5.5.1 |
|
| contig05931 |
---NA--- |
266 |
0 |
|
|
0 |
|
|
|
| contig05932 |
regulator of chromosome condensation 1 |
267 |
20 |
1.56E-31 |
86.55% |
5 |
P:mitosis; C:cytoplasm; F:guanyl-nucleotide exchange factor activity; C:nucleus; P:cell division |
|
|
| contig05933 |
---NA--- |
529 |
0 |
|
|
0 |
|
|
|
| contig05934 |
---NA--- |
221 |
0 |
|
|
0 |
|
|
|
| contig05935 |
---NA--- |
264 |
0 |
|
|
0 |
|
|
|
| contig05936 |
fibronectin type iii and spry domain containing 1 |
247 |
20 |
7.39E-34 |
77.25% |
4 |
P:mitosis; C:cytoplasm; C:microtubule; C:nucleus |
|
|
| contig05937 |
transposase yabusame-1 |
262 |
8 |
1.03E-06 |
58.13% |
0 |
|
|
|
| contig05938 |
---NA--- |
267 |
0 |
|
|
0 |
|
|
|
| contig05939 |
glyoxalase 1 |
381 |
20 |
5.49E-61 |
89.65% |
4 |
P:carbohydrate metabolic process; P:anti-apoptosis; F:zinc ion binding; F:lactoylglutathione lyase activity |
EC:4.4.1.5 |
|
| contig05940 |
phosphoribosylformylglycinamidine synthase |
273 |
20 |
1.35E-43 |
90.50% |
6 |
C:cytoplasm; P:glutamine metabolic process; P:'de novo' IMP biosynthetic process; F:protein binding; F:ATP binding; F:phosphoribosylformylglycinamidine synthase activity |
EC:6.3.5.3 |
|
| contig05941 |
---NA--- |
266 |
0 |
|
|
0 |
|
|
|
| contig05942 |
---NA--- |
251 |
0 |
|
|
0 |
|
|
|
| contig05943 |
---NA--- |
150 |
0 |
|
|
0 |
|
|
|
| contig05944 |
---NA--- |
422 |
0 |
|
|
0 |
|
|
|
| contig05945 |
---NA--- |
265 |
0 |
|
|
0 |
|
|
|
| contig05946 |
tu translation elongation mitochondrial |
602 |
20 |
4.12E-59 |
80.65% |
6 |
F:translation elongation factor activity; C:mitochondrial inner membrane; F:GTP binding; F:protein binding; P:translational elongation; F:GTPase activity |
EC:3.6.5.1; EC:3.6.5.2; EC:3.6.5.3; EC:3.6.5.4 |
|
| contig05947 |
---NA--- |
259 |
0 |
|
|
0 |
|
|
|
| contig05948 |
---NA--- |
260 |
0 |
|
|
0 |
|
|
|
| contig05949 |
valyl-trna synthetase |
503 |
20 |
6.51E-76 |
89.20% |
53 |
F:valine-tRNA ligase activity; C:MHC class I protein complex; P:protein amino acid glycosylation; P:protein amino acid phosphorylation; P:protein folding; F:zinc ion binding; C:actin filament; F:tumor necrosis factor receptor binding; F:steroid hormone receptor activity; P:cell adhesion; C:MHC class II protein complex; P:metal ion transport; C:phagocytic cup; C:PML body; ; P:regulation of small GTPase mediated signal transduction; F:ganglioside galactosyltransferase activity; P:immune response; P:cell morphogenesis; F:metal ion transmembrane transporter activity; P:phosphate transport; F:extracellular matrix structural constituent; C:extracellular space; F:protein N-terminus binding; P:androgen receptor signaling pathway; F:calcium ion binding; C:integral to membrane; P:negative regulation of transcription, DNA-dependent; C:Golgi apparatus; P:transmembrane receptor protein tyrosine kinase signaling pathway; F:RNA polymerase II transcription factor activity; C:ruffle; C:prefoldin complex; F:sequence-specific DNA binding; P:valyl-tRNA aminoacylation; P:apoptosis; F:steroid binding; C:heterochromatin; F:unfolded protein binding; F:transcription factor activity; P:cytokinesis after mitosis; F:transmembrane receptor protein tyrosine kinase activity; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; C:collagen; F:protein homodimerization activity; F:transcription factor binding; F:ATP binding; P:actin filament bundle assembly; F:androgen receptor binding; F:transcription repressor activity; C:mitochondrion; P:DNA repair; F:guanyl-nucleotide exchange factor activity |
EC:6.1.1.9; EC:2.4.1.62; EC:2.7.10.1 |
|
| contig05950 |
uncharacterized protein c1orf172 |
254 |
2 |
1.50E-05 |
60.00% |
0 |
|
|
|
| contig05951 |
alveolar soft part sarcoma chromosome candidate 1 |
295 |
20 |
2.87E-25 |
84.30% |
11 |
C:microsome; C:extrinsic to membrane; F:protein binding; C:vesicle membrane; P:glucose homeostasis; P:intracellular protein transport; C:internal side of plasma membrane; C:peripheral to membrane of membrane fraction; C:cytosol; P:regulation of glucose import; C:perinuclear region of cytoplasm |
|
|
| contig05952 |
tetraspanin 14 |
300 |
19 |
8.32E-09 |
89.11% |
1 |
C:membrane attack complex |
|
|
| contig05953 |
---NA--- |
245 |
0 |
|
|
0 |
|
|
|
| contig05954 |
family with sequence similarity member b |
239 |
20 |
1.73E-14 |
88.40% |
1 |
F:protein binding |
|
|
| contig05955 |
tnf receptor-associated factor 6 |
442 |
20 |
1.58E-31 |
78.75% |
29 |
P:response to virus; P:regulation of immunoglobulin secretion; P:positive regulation of T cell cytokine production; F:protein binding; P:T-helper 1 type immune response; F:zinc ion binding; C:membrane fraction; P:odontogenesis of dentine-containing tooth; P:response to bacterium; P:positive regulation of interleukin-2 production; P:ossification; P:positive regulation of interleukin-12 biosynthetic process; F:transcription activator activity; C:cytosol; P:JNK cascade; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:positive regulation of I-kappaB kinase/NF-kappaB cascade; P:positive regulation of smooth muscle cell proliferation; F:ubiquitin-protein ligase activity; P:T cell receptor signaling pathway; P:neural tube closure; P:activation of NF-kappaB-inducing kinase activity; P:positive regulation of interleukin-6 biosynthetic process; P:positive regulation of transcription from RNA polymerase II promoter; F:receptor activity; P:ubiquitin cycle; P:regulation of apoptosis; P:myeloid dendritic cell differentiation; P:cytokine-mediated signaling pathway |
EC:6.3.2.19 |
|
| contig05956 |
---NA--- |
272 |
0 |
|
|
0 |
|
|
|
| contig05957 |
nuclear transcription x-box binding 1 |
263 |
2 |
2.44E-08 |
84.00% |
0 |
|
|
|
| contig05958 |
amino-terminal enhancer of split |
318 |
20 |
8.06E-44 |
96.55% |
8 |
P:organ morphogenesis; P:regulation of transcription from RNA polymerase II promoter; P:Wnt receptor signaling pathway; F:transcription corepressor activity; P:skeletal system development; C:nucleus; P:negative regulation of transcription; P:regulation of growth |
|
|
| contig05959 |
queuine trna-ribosyltransferase 1 |
276 |
20 |
8.46E-38 |
92.70% |
5 |
F:queuine tRNA-ribosyltransferase activity; C:ribosome; P:zinc ion transport; P:queuosine biosynthetic process; F:zinc ion binding |
EC:2.4.2.29 |
|
| contig05960 |
fascin homolog actin-bundling protein (strongylocentrotus purpuratus) |
241 |
20 |
1.40E-32 |
86.70% |
6 |
F:protein binding, bridging; C:filopodium; P:actin filament bundle assembly; F:actin filament binding; C:actin cytoskeleton; P:cell proliferation |
|
|
| contig05961 |
---NA--- |
431 |
0 |
|
|
0 |
|
|
|
| contig05962 |
---NA--- |
240 |
0 |
|
|
0 |
|
|
|
| contig05963 |
---NA--- |
399 |
0 |
|
|
0 |
|
|
|
| contig05964 |
---NA--- |
246 |
0 |
|
|
0 |
|
|
|
| contig05965 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
| contig05966 |
---NA--- |
408 |
0 |
|
|
0 |
|
|
|
| contig05967 |
vacuolar protein sorting 36 |
297 |
20 |
2.49E-37 |
96.60% |
8 |
F:lipid binding; C:late endosome; C:lysosome; P:endosome transport; F:ubiquitin binding; C:nucleus; P:regulation of transcription, DNA-dependent; P:protein transport |
|
|
| contig05968 |
alpha- -mannosyltransferase alg12 |
543 |
20 |
2.79E-31 |
67.55% |
4 |
P:protein amino acid N-linked glycosylation; F:alpha-1,6-mannosyltransferase activity; C:endoplasmic reticulum; C:membrane part |
|
|
| contig05969 |
dimeric dihydrodiol dehydrogenase |
246 |
20 |
2.92E-14 |
74.75% |
5 |
F:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity; P:metabolic process; F:binding; P:electron transport; F:D-xylose 1-dehydrogenase (NADP+) activity |
EC:1.3.1.20; EC:1.1.1.179 |
|
| contig05970 |
alanine aminotransferase |
461 |
20 |
3.58E-37 |
69.55% |
1 |
F:transferase activity, transferring nitrogenous groups |
|
|
| contig05971 |
zinc finger protein 37 homolog |
609 |
20 |
2.51E-75 |
55.70% |
1 |
F:binding |
|
|
| contig05972 |
wd repeat domain 61 |
701 |
20 |
1.98E-75 |
83.95% |
2 |
F:F; P:P |
|
|
| contig05973 |
---NA--- |
261 |
0 |
|
|
0 |
|
|
|
| contig05974 |
arginine serine-rich coiled-coil 2 |
241 |
20 |
1.28E-17 |
88.80% |
2 |
F:F; C:C |
|
|
| contig05975 |
zinc finger protein 330 |
284 |
20 |
4.03E-40 |
95.20% |
5 |
C:nucleolus; C:chromosome, centromeric region; C:midbody; F:zinc ion binding; F:protein binding |
|
|
| contig05976 |
biogenesis of lysosome-related organelles complex-1 subunit 3 |
567 |
20 |
3.11E-63 |
60.05% |
2 |
P:developmental pigmentation; F:protein binding |
|
|
| contig05977 |
---NA--- |
253 |
0 |
|
|
0 |
|
|
|
| contig05978 |
adenosine trna-specific 1 |
362 |
20 |
7.45E-26 |
69.65% |
3 |
F:RNA binding; F:tRNA-specific adenosine deaminase activity; P:tRNA processing |
|
|
| contig05979 |
solute carrier family (neutral amino acid y+ system) member 10 |
240 |
20 |
1.90E-29 |
94.30% |
8 |
C:integral to plasma membrane; C:dendrite; P:L-serine transport; F:D-serine transmembrane transporter activity; F:protein binding; F:L-serine transmembrane transporter activity; P:D-serine transport; P:D-alanine transport |
|
|
| contig05980 |
replication protein 70kda |
260 |
20 |
6.88E-19 |
56.90% |
2 |
F:binding; C:nucleus |
|
|
| contig05981 |
novel protein |
880 |
1 |
1.64E-20 |
59.00% |
0 |
|
|
|
| contig05982 |
---NA--- |
248 |
0 |
|
|
0 |
|
|
|
| contig05983 |
---NA--- |
269 |
0 |
|
|
0 |
|
|
|
| contig05984 |
---NA--- |
200 |
0 |
|
|
0 |
|
|
|
| contig05985 |
---NA--- |
214 |
0 |
|
|
0 |
|
|
|
| contig05986 |
---NA--- |
231 |
0 |
|
|
0 |
|
|
|
| contig05987 |
---NA--- |
216 |
0 |
|
|
0 |
|
|
|
| contig05988 |
hydroxysteroid (17-beta) dehydrogenase 7 |
241 |
20 |
1.15E-26 |
84.05% |
9 |
F:estradiol 17-beta-dehydrogenase activity; ; F:prolactin receptor binding; P:female pregnancy; P:signal transduction; P:cholesterol biosynthetic process; C:integral to membrane; F:3-keto sterol reductase activity; C:endoplasmic reticulum |
EC:1.1.1.62; EC:1.1.1.270 |
|
| contig05989 |
peroxisome proliferator-activated receptor beta |
246 |
20 |
9.08E-16 |
98.10% |
8 |
F:zinc ion binding; P:zinc ion transport; P:regulation of transcription, DNA-dependent; F:sequence-specific DNA binding; F:transcription factor activity; P:transcription antitermination; F:steroid hormone receptor activity; C:nucleus |
|
|
| contig05990 |
---NA--- |
313 |
0 |
|
|
0 |
|
|
|
| contig05991 |
---NA--- |
241 |
0 |
|
|
0 |
|
|
|
| contig05992 |
---NA--- |
246 |
0 |
|
|
0 |
|
|
|
| contig05993 |
von willebrand factor a domain-containing protein 2 precursor (a domain-containing protein matrilin and collagen) (colon cancer secreted protein 2) (ccsp-2) |
254 |
20 |
3.21E-24 |
82.85% |
2 |
F:identical protein binding; C:extracellular region |
|
|
| contig05994 |
---NA--- |
269 |
0 |
|
|
0 |
|
|
|
| contig05995 |
sept2 protein |
300 |
20 |
1.79E-19 |
90.80% |
6 |
F:GTP binding; F:protein binding; P:cell cycle; C:septin complex; C:nucleus; P:cell division |
|
|
| contig05996 |
sphingomyelin phosphodiesterase isoform cra_a |
576 |
20 |
2.46E-51 |
73.25% |
20 |
P:sphingomyelin metabolic process; F:hydrolase activity; F:metal ion binding; C:integral to membrane; C:membrane; P:peptide hormone secretion; P:cell cycle; F:sphingomyelin phosphodiesterase activity; C:Golgi membrane; P:multicellular organismal development; C:Golgi cis cisterna; P:P; P:signal transduction; P:response to stress; C:Golgi apparatus; C:membrane fraction; F:magnesium ion binding; C:plasma membrane; C:C; P:sphingomyelin catabolic process |
|
|
| contig05997 |
novel protein |
284 |
3 |
7.92E-12 |
72.00% |
0 |
|
|
|
| contig05998 |
---NA--- |
336 |
0 |
|
|
0 |
|
|
|
| contig05999 |
edem2 protein |
285 |
4 |
2.63E-10 |
90.50% |
2 |
F:calcium ion binding; C:membrane |
|
|
| contig06000 |
---NA--- |
137 |
0 |
|
|
0 |
|
|
|
100 Rows returned.
Helpdesk 